Evidence map›Paper›PMID 41735533›Full record

ArticleNature immunology2026

Lymphocyte-derived cholinergic circuits modulate germinal center output and B cell activation.

Duygu Nechanitzky, Logan K Smith, Robert Nechanitzky, Soode Moghadas Jafari, Jillian Haight, Christophe Bontoux, Parameswaran Ramachandran, Matthew J Gold, Andrew C Wakeham, Mary E Saunders and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Duygu Nechanitzky *Princess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network, Toronto, Ontario, Canada.
Logan K Smith *Princess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network, Toronto, Ontario, Canada.
Robert Nechanitzky *Princess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network, Toronto, Ontario, Canada.
Soode Moghadas JafariPrincess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network, Toronto, Ontario, Canada.
Jillian HaightPrincess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network, Toronto, Ontario, Canada.
Christophe BontouxDepartment of Pathology, Cancer University Institute of Toulouse-Oncopole, University Hospital of Toulouse, University of Toulouse III Paul Sabatier, INSERM U1037, Cancer Research Center in Toulouse, Toulouse, France.ORCID http://orcid.org/0000-0001-5446-6197
Parameswaran RamachandranPrincess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network, Toronto, Ontario, Canada.
Matthew J GoldPrincess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network, Toronto, Ontario, Canada.
Andrew C WakehamPrincess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network, Toronto, Ontario, Canada.
Mary E SaundersPrincess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network, Toronto, Ontario, Canada.
Justin F DenisetDepartment of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, Canada.
Tak W MakPrincess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network, Toronto, Ontario, Canada. Tak.Mak@uhn.ca.ORCID http://orcid.org/0000-0001-6766-861X

Funding

Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) Application #470754
6 · The paper itself

Abstract

Germinal centers (GCs) are specialized lymphoid structures in which activated B cells undergo clonal selection and B cell receptor (BCR) somatic hypermutation to generate high-affinity antibodies. Previous work has shown that T cells expressing choline acetyltransferase (ChAT), the enzyme that synthesizes acetylcholine (ACh), are linked to the production of high-affinity antibodies in the GC response. However, whether B cells in the GC also express ChAT, and the details of the interplay of cholinergic circuits within the GC, remain unclear. Here we show that Chat expressed by GC B cells contributes to the early accumulation of high-affinity GC B cells following antigen encounter. We identify key transcriptional regulators of Chat expression in GC B cells and demonstrate that ACh receptor (AChR) expression is dynamically coordinated during B cell activation. In vitro, we show that ACh binding to muscarinic AChRs limits plasma cell differentiation and dampens BCR signal transduction to fine-tune the threshold for affinity-based positive selection. Together, these findings reveal a previously unrecognized regulatory axis that operates early during GC selection and uses cholinergic signals to shape B cell fate decisions and humoral immunity.

Indexed as

AcetylcholineB-LymphocytesCholine O-AcetyltransferaseGerminal CenterLymphocyte ActivationAnimalsCell DifferentiationImmunity, HumoralMiceMice, Inbred C57BLMice, KnockoutReceptors, Antigen, B-CellSignal TransductionAcetylcholineCholine O-AcetyltransferaseReceptors, Antigen, B-Cell

Identifiers

PMID41735533

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.